Trial Information

Safety and Effectiveness Trial of the Ventana Fenestrated Stent Graft System

Official Title: Prospective, Multicenter, Single Arm Safety and Effectiveness Trial of the Endologix Fenestrated Stent Graft System for the Endovascular Repair of Juxtarenal/Pararenal (JAA/PAA) Aneurysms

Summary

The purpose of this trial is to determine if the Ventana Fenestrated Stent Graft System is safe and effective for the endovascular repair of juxtarenal or pararenal aortic aneurysms.

Phase: Phase 2

Sponsor: Endologix

Overall Contacts:

Jennifer Jelf
949-595-7259
jjelf@endologix.com

Dana Deyette, RN
Phone: 949-595-7276
ddeyette@endologix.com

Locations (22)

Country	State	City	Zip	Facility and Contact
United States	Alabama	Birmingham	35429	University of Alabama at Birmingham Donna Kerns, RN 205-934-7279 William D Jordan Jr, MD Principal Investigator
United States	Arizona	Phoenix	85016	Arizona Heart Institute Laura Vigliotti, MA 602-604-5211 Julio Rodriguez-Lopez, MD Principal Investigator
United States	California	Concord	94520	East Bay Cardiovascular & Thoracic Associates Tish Murphy, RN 925-674-2198 Tanveer Khan, MD Principal Investigator
United States	California	Los Angeles	90095	UCLA Medical Center Kathy Walden-Land, RN 310-206-1115 William Quinones-Baldrich, MD Principal Investigator
United States	Florida	Gainesville	32608	VA Gainesville Anne Irwin, RN 352-376-1611 ext. 6965 Peter R Nelson, MD, MS Principal Investigator
United States	Georgia	Atlanta	30322	Emory University Ravi Veeraswamy, MD 404-556-4744 Ravi Veeraswamy, MD Principal Investigator
United States	Indiana	Indianapolis	46202	Indiana University Janet Klein, RN 317-962-0287 Alan Sawchuk, MD Principal Investigator
United States	Kentucky	Louisville	40207	Baptist East Hospital Shannon Buckman 502-638-5124 Thomas Bergamini, MD Principal Investigator
United States	Massachusetts	Boston	02115	Brigham and Women's Hospital Amanda Shanner 617-525-8555 Edwin Gravereaux, MD Principal Investigator
United States	Massachusetts	Boston	02114	Massachusetts General Hospital Jennifer Finn, RN 617-726-4957 Christopher J Kwolek, MD Principal Investigator
United States	Minnesota	Rochester	55905	Mayo Clinic Sharon Mueller 507-538-0992 Gustavo Oderich, MD Principal Investigator
United States	Missouri	St. Louis	63110	Barnes-Jewish Hospital Christine Keller, RN Luis Sanchez, MD Principal Investigator
United States	New Hampshire	Lebanon	03756	Dartmouth-Hitchcock Medical Center Sharon Segel, RN Mark Fillinger, MD Principal Investigator
United States	North Carolina	Chapel Hill	27599	University of North Carolina Dianne Glover dianne_glover@med.unc.edu Mark Farber, MD Principal Investigator
United States	Ohio	Cleveland	44195	Cleveland Clinic Foundation Donna Fleming, RN 216-444-1069 Matthew Eagleton, MD Principal Investigator
United States	Pennsylvania	Philadelphia	19104	Hospital of the University of Pennsylvania Linda Mark, RN 215-662-6091 Edward Woo, MD Principal Investigator
United States	Pennsylvania	Pittsburgh	15232	UPMC Suzanne David, RN 412-623-8443 Michel Makaroun, MD Principal Investigator
United States	Tennessee	Memphis	38120	Baptist Memorial Hospital Suzanne Burgar, PA-C 901-747-1247 H. Edward Garrett Jr., MD Principal Investigator
United States	Texas	Houston	77030	Methodist Hospital Anastasia Bass 713-441-6539 Alan Lumsden, MD Principal Investigator
United States	Washington	Seattle	98104	Harborview Medical Center Billi Tatum, RN 206-744-3369 Benjamin W Starnes, MD Principal Investigator
United States	West Virginia	Charleston	25304	Charleston Area Medical Center Christina Bethea 304-388-9679 christina.bethea@camc.org Shadi Abu-Halimah, M.D Principal Investigator
United States	Wisconsin	Milwaukee	53215	Aurora St. Luke's Medical Center Christina Schreiter, RN 414-385-2728 Mark Mewissen, MD Principal Investigator

NCT ID:NCT01491945

Date Last Changed: October 3, 2012